Personalised cancer medicine is advancing, but better biomarker testing, clinical [...]

Formation Bio has launched a $600 million fund to acquire [...]

Researchers at ETH Zurich have developed an electrically powered implant [...]

Mineralys Therapeutics has reported Phase 3 data showing lorundrostat reduced [...]

SalubrisBio has reported Phase 1b/2 results for its investigational antibody-drug [...]

Tango Therapeutics has reported an 82% objective response rate with [...]

A US observational study of nearly 7,000 adults with HIV-1 [...]

AmplexDiagnostics has launched a CE-IVD molecular diagnostic test that detects [...]

SeaBeLife has secured €2.9 million in French government funding to [...]

Ryvu Therapeutics has reported preclinical results for RVU602, an experimental [...]